Navigation Links
Catilin Receives Renewable Energy Award for Pilot Plant
Date:3/11/2009

Iowa Department of Economic Development Awards Funds to Catilin, Inc.

AMES, Iowa, March 11 /PRNewswire/ -- Catilin, Inc., a leading catalyst technology company for biofuels, announced today a Demonstration Fund award of $150,000 by the Iowa Department of Economic Development. The award is targeted for the upgrade of Catilin's biodiesel pilot plant, from batch to continuous operation mode. Operation of the pilot plant in the continuous mode is the final step in the rigorous commercialization process of the world's first heterogeneous (solid) biodiesel catalyst: Catilin's T300 Biodiesel Catalyst.

Biodiesel is commonly produced using a homogeneous (liquid) catalyst, such as sodium hydroxide or sodium methylate. These catalysts require excessive amounts of water, energy, toxic chemicals, and equipment to produce the biodiesel and glycerin co-products. Catilin's heterogeneous catalyst, on the other hand, does not suffer these traits and is also non-toxic, a critical issue throughout the U.S. and around the globe. Additionally, the T300 Catalyst can be used in existing plants with minimal modification as it reacts at common operational temperatures and pressure.

"We are pleased to receive the Iowa Demonstration Fund award. It validates our extensive and successful testing in our lab and now in our continuous process flow pilot plant. Our pilot plant produces 300,000 gallons of high-quality biodiesel per year utilizing Catilin's ground-breaking T300 Catalyst," said Larry Lenhart, Catilin President and CEO.

Catilin's pilot plant is located within the BECON (Biomass Energy Conversion) facility outside of Ames, IA. The pilot plant is open to visitors, prospective partners and customers.

About Catilin

Catilin, Inc. is a catalyst technology company that is revolutionizing biofuels production. Catilin has a unique, new technology for biodiesel production that greatly reduces the cost of producing a gallon of biodiesel while creating a superior quality biodiesel and glycerin by-product. Catilin's patent-pending, non-toxic technology is centered on a family of solid heterogeneous catalysts that can be easily utilized within existing production facilities, can be reused multiple times and works with virtually every biodiesel feedstock source.

The pioneering research of Catilin, in conjunction with Ames Laboratory and Iowa State University, continues to focus on the future of biodiesel, including the award-winning research on algae to biodiesel. Catilin is backed by Silicon Valley-based venture capital firms MDV-Mohr Davidow Ventures and Leader Ventures. For more information, please visit the website http://www.catilin.com

About the Demonstration Fund

In August 2007, the Legislature approved the creation of the Demonstration Fund through the Iowa Department of Economic Development to provide pre-seed capital grants of up to $150,000 to encourage prototype and concept development activities by small-and medium-sized Iowa companies in the advanced manufacturing, biosciences, and information technology industries. The fund is designed to encourage commercialization of innovation to foster competitive, profitable companies that create high paying jobs and wealth in Iowa. For more information, go to the website http://www.iowalifechanging.com/business/ic/demonstration_fund.html


'/>"/>
SOURCE Catilin, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System
2. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
3. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
4. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
5. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
6. Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee
7. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
8. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
9. IlluminOss Medical Receives ISO 13485 Certification
10. Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
11. NeoStem Receives Notice of Noncompliance from NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):